These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 28184446

  • 1. Lymphovascular invasion predicts poor prognosis in high-grade pT1 bladder cancer patients who underwent transurethral resection in one piece.
    Ukai R, Hashimoto K, Nakayama H, Iwamoto T.
    Jpn J Clin Oncol; 2017 May 01; 47(5):447-452. PubMed ID: 28184446
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of the lymphovascular invasion in high-grade stage pT1 bladder cancer.
    Branchereau J, Larue S, Vayleux B, Karam G, Bouchot O, Rigaud J.
    Clin Genitourin Cancer; 2013 Jun 01; 11(2):182-8. PubMed ID: 23276589
    [Abstract] [Full Text] [Related]

  • 3. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM, Simons CM, Konety BR, Muirhead DM, Williams RD, O'Donnell MA, Joudi FN.
    BJU Int; 2009 Feb 01; 103(4):475-9. PubMed ID: 18990174
    [Abstract] [Full Text] [Related]

  • 4. The Impact of Lymphovascular Invasion on Risk of Upstaging and Lymph Node Metastasis at the Time of Radical Cystectomy.
    Werntz RP, Smith ZL, Packiam VT, Smith N, Steinberg GD.
    Eur Urol Focus; 2020 Mar 15; 6(2):292-297. PubMed ID: 30297221
    [Abstract] [Full Text] [Related]

  • 5. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP, You L, Zhang Y, Daignault S, Montie JE, Lee CT.
    J Urol; 2008 Nov 15; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [Abstract] [Full Text] [Related]

  • 6. Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder.
    Abufaraj M, Shariat SF, Foerster B, Pozo C, Moschini M, D'Andrea D, Mathieu R, Susani M, Czech AK, Karakiewicz PI, Seebacher V.
    World J Urol; 2018 Feb 15; 36(2):231-240. PubMed ID: 29127452
    [Abstract] [Full Text] [Related]

  • 7. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
    Cho KS, Seo HK, Joung JY, Park WS, Ro JY, Han KS, Chung J, Lee KH.
    J Urol; 2009 Dec 15; 182(6):2625-30. PubMed ID: 19836779
    [Abstract] [Full Text] [Related]

  • 8. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
    Shariat SF, Bolenz C, Godoy G, Fradet Y, Ashfaq R, Karakiewicz PI, Isbarn H, Jeldres C, Rigaud J, Sagalowsky AI, Lotan Y.
    J Urol; 2009 Jul 15; 182(1):78-84; discussion 84. PubMed ID: 19447418
    [Abstract] [Full Text] [Related]

  • 9. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y, Gupta A, Shariat SF, Palapattu GS, Vazina A, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Perotte P, Schoenberg MP, Lerner SP, Sagalowsky AI.
    J Clin Oncol; 2005 Sep 20; 23(27):6533-9. PubMed ID: 16116151
    [Abstract] [Full Text] [Related]

  • 10. Poor prognostic value of lymphovascular invasion for pT1 urothelial carcinoma with squamous differentiation in bladder cancer.
    Li G, Song H, Wang J, Bao Y, Niu Y.
    Sci Rep; 2016 Jun 09; 6():27586. PubMed ID: 27279531
    [Abstract] [Full Text] [Related]

  • 11. Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.
    Tilki D, Shariat SF, Lotan Y, Rink M, Karakiewicz PI, Schoenberg MP, Lerner SP, Sonpavde G, Sagalowsky AI, Gupta A.
    BJU Int; 2013 Jun 09; 111(8):1215-21. PubMed ID: 23181623
    [Abstract] [Full Text] [Related]

  • 12. The presence of lymphovascular invasion in radical cystectomy specimens from patients with urothelial carcinoma portends a poor clinical prognosis.
    Canter D, Guzzo T, Resnick M, Magerfleisch L, Sonnad S, Bergey M, Tomazewski J, Vaughn D, Van Arsdalen K, Malkowicz B.
    BJU Int; 2008 Sep 09; 102(8):952-7. PubMed ID: 18485042
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical assessment of lymphatic and blood vessel invasion in T1 urothelial carcinoma of the bladder.
    Gakis G, Todenhöfer T, Braun M, Fend F, Stenzl A, Perner S.
    Scand J Urol; 2015 Sep 09; 49(5):382-7. PubMed ID: 25921278
    [Abstract] [Full Text] [Related]

  • 14. Lymphovascular invasion is associated with oncologic outcomes following radical cystectomy for squamous cell carcinoma of the urinary bladder.
    Spradling K, Lotan Y, Shokeir A, Abol-Enein H, Mosbah A, Morgan JB, Ghoneim M, Youssef RF.
    Urol Oncol; 2016 Sep 09; 34(9):417.e1-8. PubMed ID: 27157247
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy.
    Quek ML, Stein JP, Nichols PW, Cai J, Miranda G, Groshen S, Daneshmand S, Skinner EC, Skinner DG.
    J Urol; 2005 Jul 09; 174(1):103-6. PubMed ID: 15947587
    [Abstract] [Full Text] [Related]

  • 16. Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial.
    Bolenz C, Herrmann E, Bastian PJ, Michel MS, Wülfing C, Tiemann A, Buchner A, Stief CG, Fritsche HM, Burger M, Wieland WF, Höfner T, Haferkamp A, Hohenfellner M, Müller SC, Ströbel P, Trojan L.
    BJU Int; 2010 Aug 09; 106(4):493-9. PubMed ID: 20067452
    [Abstract] [Full Text] [Related]

  • 17. Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.
    Lotan Y, Bagrodia A, Passoni N, Rachakonda V, Kapur P, Arriaga Y, Bolenz C, Margulis V, Raj GV, Sagalowsky AI, Shariat SF.
    Eur Urol; 2013 Sep 09; 64(3):465-71. PubMed ID: 23571005
    [Abstract] [Full Text] [Related]

  • 18. Impact of lymphovascular invasion on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection.
    Sha N, Xie L, Chen T, Xing C, Liu X, Zhang Y, Shen Z, Xu H, Wu Z, Hu H, Wu C.
    Onco Targets Ther; 2015 Sep 09; 8():3401-6. PubMed ID: 26604797
    [Abstract] [Full Text] [Related]

  • 19. Prognostic factors in patients with stage pT0/pT1/pTa in the radical cystectomy specimen.
    Husillos-Alonso A, Herranz Amo F, Subirá-Ríos D, Díez-Cordero JM, Moralejo-Gárate M, López-López E, Piñero-Sánchez J, Ogaya Pinies G, Lledó-García E, Hernández-Fernández C.
    Arch Esp Urol; 2013 Oct 09; 66(8):787-95. PubMed ID: 24136482
    [Abstract] [Full Text] [Related]

  • 20. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R, Gentile BC, Mirabile G, Albanesi L, Tariciotti P, Rizzo G, Buscarini M, Vermiglio M.
    Arch Ital Urol Androl; 2017 Dec 31; 89(4):272-276. PubMed ID: 29473376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.